VCYT
Veracyte Inc
NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$31.78
-4.94% today
Updated 2026-04-29
Market cap
$2.67B
P/E ratio
40.77
P/S ratio
5.16x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$23 – $51
Volume
0.9M
Veracyte Inc (VCYT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+123.8%
Last 4 quarters
Revenue YoY growth
+18.5%
Most recent quarter
EPS YoY growth
+47.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+15.2%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+26.3%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $0.53 | +35.9% | $35.69 | $38.75 | +8.6% |
| 2025-11-04 | $0.51 | +59.4% | $36.45 | $46.04 | +26.3% |
| 2025-08-06 | $0.44 | +300.0% | $25.01 | $27.68 | +10.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.39 | $0.53 | +35.9% | $140.64M | +18.5% |
| 2025-09-30 | $0.32 | $0.51 | +59.4% | $131.87M | +13.8% |
| 2025-06-30 | $0.11 | $0.44 | +300.0% | $130.16M | +13.8% |
| 2025-03-31 | $-0.17 | $0.31 | +282.4% | $114.47M | +18.2% |
| 2024-12-31 | $0.26 | $0.36 | +40.0% | $118.63M | +20.8% |
| 2024-09-30 | $0.03 | $0.19 | +533.3% | $115.86M | +28.6% |
| 2024-06-30 | $-0.02 | $0.07 | +450.0% | $114.43M | +26.7% |
| 2024-03-31 | $-0.16 | $-0.02 | +87.5% | $96.84M | — |
| 2023-12-31 | $-0.09 | $-0.39 | -333.3% | $98.20M | — |
| 2023-09-30 | $-0.15 | $-0.41 | -173.3% | $90.11M | — |
| 2023-06-30 | $-0.15 | $-0.12 | +20.0% | $90.32M | — |
Frequently asked questions
Has Veracyte Inc beaten earnings estimates?
Veracyte Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +123.8% over the last 4 quarters.
How does VCYT stock react to earnings?
VCYT stock has moved an average of +15.2% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Veracyte Inc's revenue growth rate?
Veracyte Inc reported year-over-year revenue growth of +18.5% in its most recent quarter, with EPS growing +47.2% year-over-year.